James J. Bochnowski

This profile gathers the share dealings of James J. Bochnowski in Jaguar Health, Inc., where the filings describe the role as board member. In total, 12 filings cover trades dated from 18 May 2015 to 11 December 2025.

The open-market side counts 3 purchases for €727k alongside 2 sales for €639. Netting one side against the other leaves €726k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants and 2 option exercises.

In size, the median ticket on the buying side is €324k. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 15 December 2025, the filings show a share grant in Jaguar Health, Inc. The most recent open-market purchase was published on 25 July 2019, 2,648 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.